Biogen Idec Company
.png)
Biogen Idec is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Technology:
NeuroPharmacology
Industry:
Biotechnology, Health Care, Healthcare and Support, Neuroscience, Therapeutics
Headquarters:
Weston, Massachusetts, United States
Founded Date:
1978
Employees Number:
5001-10000
Funding Status:
IPO
Acquisitions Number:
9
Total Funding:
2643521
Estimated Revenue:
$1B to $10B
Register and Claim Ownership